Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 15, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal Stromal Tumor (GIST) Drug Sales in these regions, from 2013 to 2025 (forecast), covering North America Europe China Japan Southeast Asia India Access Report Details at: https://www.themarketreports.com/report/global-gastrointestinal-stromal-tumor-gist-drug-sales-market-report-2018 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Ariad Pharmaceuticals, Inc. Arog Pharmaceuticals, Inc. Array Biopharma Inc. Astex Pharmaceuticals, Inc. Blueprint Medicines Corporation Boston Biomedical, Inc. Calithera Biosciences, Inc. Chipscreen Biosciences Ltd Deciphera Pharmaceuticals, Llc F. Hoffmann-La Roche Ltd. Horizon Pharma Plc Immunicum Ab Jiangsu Hengrui Medicine Co., Ltd. Kolltan Pharmaceuticals, Inc. Natco Pharma Limited Nerviano Medical Sciences S.R.L. Novartis Ag Omeros Corporation Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1126003 On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Amcasertib Anagrelide hydrochloride CR APG-1351 Binimetinib Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Gastrointestinal Stromal Tumor (GIST) Drug Sales for each application, including Clinic Hospital Others Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/1126003
The Market Reports
Shirish Gupta
+1-631-407-1315
web@themarketreports.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|